logo-loader

Biogen Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$40.59 billion
Price
220.06 USD
Change
-2.46%
52 weeks high
343.75
52 weeks low
215.81

In brief

Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis.